Nucleic acid aptamers for biosensors and bio-analytical applications. 2009

Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
Center for Research at Bio/nano Interface, Department of Chemistry, Shands Cancer Center, UF Genetics Institute, University of Florida, Gainesville, FL 32611-7200, USA.

Oligonucleotides were once considered only functional as molecules for the storage of genetic information. However, the discovery of RNAzymes, and later, DNAzymes, unravelled the innate potential of oligonucleotides in many other biological applications. In the last two decades, these applications have been further expanded through the introduction of Systematic Evolution of Ligands by EXponential enrichment (SELEX) which has generated, by repeated rounds of in vitro selection, a type of molecular probe termed aptamers. Aptamers are oligonucleic acid (or peptide) molecules that can bind to various molecular targets and are viewed as complements to antibodies. Aptamers have found applications in many areas, such as bio-technology, medicine, pharmacology, microbiology, and analytical chemistry, including chromatographic separation and biosensors. In this review, we focus on the use of aptamers in the development of biosensors. Coupled with their ability to bind a variety of targets, the robust nature of oligonucleotides, in terms of synthesis, storage, and wide range of temperature stability and chemical manipulation, makes them highly suitable for biosensor design and engineering. Among the many design strategies, we discuss three general paradigms that have appeared most frequently in the literature: structure-switching, enzyme-based, and aptazyme-based designs.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D000077214 Becaplermin A recombinant human platelet-derived growth factor B-chain dimer used to promote WOUND HEALING by stimulating PHYSIOLOGIC ANGIOGENESIS. PDGF-BB,Platelet-Derived Growth Factor BB,Platelet-Derived Growth Factor BB, Recombinant,Recombinant Platelet-Derived Growth Factor BB,Regranex,rPDGF-BB,rhPDGF-BB,Platelet Derived Growth Factor BB,Platelet Derived Growth Factor BB, Recombinant,Recombinant Platelet Derived Growth Factor BB
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015374 Biosensing Techniques Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal. Bioprobes,Biosensors,Electrodes, Enzyme,Biosensing Technics,Bioprobe,Biosensing Technic,Biosensing Technique,Biosensor,Electrode, Enzyme,Enzyme Electrode,Enzyme Electrodes,Technic, Biosensing,Technics, Biosensing,Technique, Biosensing,Techniques, Biosensing
D052156 SELEX Aptamer Technique A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS. Systematic Evolution of Ligands by Exponential Enrichment,Aptamer Technique, SELEX,Aptamer Techniques, SELEX,SELEX Aptamer Techniques,Technique, SELEX Aptamer,Techniques, SELEX Aptamer
D052157 Aptamers, Nucleotide Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity. DNA Aptamer,DNA Aptamers,RNA Aptamers,Rna Aptamer,Nucleotide Aptamers,Oligonucleotide Ligands, DNA,Oligonucleotide Ligands, RNA,Aptamer, DNA,Aptamer, Rna,Aptamers, DNA,Aptamers, RNA,DNA Oligonucleotide Ligands,RNA Oligonucleotide Ligands
D054802 Molecular Imprinting A methodology for chemically synthesizing polymer molds of specific molecules or recognition sites of specific molecules. Applications for MOLECULARLY IMPRINTED POLYMERS (MIPs) include separations, assays and biosensors, and catalysis. Molecular Imprinting Technique,Imprinting, Molecular,Imprinting Technique, Molecular,Imprinting Techniques, Molecular,Molecular Imprinting Techniques,Technique, Molecular Imprinting,Techniques, Molecular Imprinting
D020574 Proto-Oncogene Proteins c-sis Cellular DNA-binding proteins encoded by the sis gene (GENES, SIS). c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis. PDGFB,Platelet-Derived Growth Factor B,c-sis Proteins,sis Proto-Oncogene Proteins,Proto-Oncogene Products c-sis,Proto-Oncogene Protein sis,Proto-Oncogene Proteins sis,Platelet Derived Growth Factor B,Proto Oncogene Products c sis,Proto Oncogene Protein sis,Proto Oncogene Proteins c sis,Proto Oncogene Proteins sis,Proto-Oncogene Proteins, sis,c sis Proteins,sis Proto Oncogene Proteins,sis, Proto-Oncogene Protein,sis, Proto-Oncogene Proteins

Related Publications

Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
January 2020, Analytical and bioanalytical chemistry,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
January 2015, Critical reviews in biomedical engineering,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
August 1998, Analytical chemistry,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
September 2005, Journal of biomolecular techniques : JBT,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
April 2020, Nucleic acids research,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
December 2017, Current opinion in biotechnology,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
January 2019, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
May 2014, Molecular and clinical oncology,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
January 2011, Current medicinal chemistry,
Kwame Sefah, and Joseph A Phillips, and Xiangling Xiong, and Ling Meng, and Dimitri Van Simaeys, and Hui Chen, and Jennifer Martin, and Weihong Tan
November 2023, Trends in biotechnology,
Copied contents to your clipboard!